Utama › Sindrom Usus Rengsa › Florida
Kajian klinikal Sindrom Usus Rengsa di Florida
6 kajian untuk Sindrom Usus Rengsa sedang mencari peserta di lokasi di Florida.
Bandar di Florida
Teks kajian rasmi (Bahasa Inggeris)
A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M)
- GSK Investigational Site, Brandon
- GSK Investigational Site, Clearwater
- GSK Investigational Site, Coral Gables
- dan 29 lagi
Mengambil pesertaFasa 2
Umur 18 hingga 80 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07519395A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Constipation (IBS-C)
- Encore Medical Research, Hollywood
Mengambil pesertaFasa 2
Umur 18 hingga 75 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07545772A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Diarrhea (IBS-D)
- Encore Medical Research, Hollywood
- Clinical Research of Osceola, Kissimmee
Mengambil pesertaFasa 2
Umur 18 hingga 75 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07545759A Prospective Trial of a Variable Compression System for Moderate to Severe Irritable Bowel Syndrome
- Central Florida Gastro Research, Kissimmee
Mengambil peserta
Umur 18 hingga 60 · Semua jantina · Dikemas kini 29 Apr 2026 · NCT07540312Novel Pilot Study to Treat Symptoms of IBS With Diarrhea Using Combination Therapy of a Low-FODMAP Diet and a Neuromodulator
- Mayo Clinic, Jacksonville
Mengambil pesertaFasa awal 1
Umur 18 hingga 70 · Semua jantina · Dikemas kini 18 Dis 2025 · NCT06684470The Use of Directed Probiotics in ME/CFS: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
- Institute for Neuroimmune Medicine, Fort Lauderdale
Mengambil pesertaFasa 2
Umur 45 hingga 70 · Semua jantina · Dikemas kini 4 Mac 2025 · NCT06211062Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.